Evaluation of clinical and laboratory data for early diagnosis of heparin-induced thrombocytopenia

Am J Health Syst Pharm. 2015 Oct 1;72(19):1649-55. doi: 10.2146/ajhp140778.

Abstract

Purpose: Results of a study to determine the utility of combining laboratory values and clinical probability scores to improve the detection of heparin-induced thrombocytopenia (HIT) are reported.

Methods: In a retrospective, single-site, chart review-based investigation, 156 cases in which patients with suspected HIT had positive results on a widely used diagnostic test (the anti-heparin/platelet factor 4, or anti-PF4, assay) were identified; in all cases, the blood specimens had been sent to a reference laboratory for confirmation of HIT via serotonin release assay (SRA). After investigator scoring of the clinical probability of HIT in each case by the 4T's method, a multiple logistic regression model was used to evaluate the combined effect of 4T's scores and anti-PF4 assay values in predicting SRA results.

Results: 4T's scores indicating an intermediate or high probability of HIT combined with high anti-PF4 test values (i.e., optical density [OD] value of ≥1.4) were strongly predictive of a positive SRA result, as were high-probability 4T's scores alone. Low-probability 4T's scores alone or in combination with anti-PF4 OD values of <1.4 were highly correlated with negative SRA results. Controlling for potential confounding factors, logistic regression analysis indicated that the 4T's score was a better predictor of SRA results than the anti-PF4 test value.

Conclusion: The combination of anti-PF4 OD values and 4T's scores accurately predicted SRA results, suggesting that the SRA may not be necessary to confirm HIT in patients with a relatively low 4T's score and a low anti-PF4 OD value.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Early Diagnosis
  • Female
  • Hematologic Tests / methods*
  • Heparin / adverse effects*
  • Humans
  • Logistic Models
  • Male
  • Middle Aged
  • Platelet Factor 4 / metabolism
  • Prognosis
  • Retrospective Studies
  • Risk Assessment
  • Thrombocytopenia / chemically induced*
  • Thrombocytopenia / diagnosis*

Substances

  • Platelet Factor 4
  • Heparin